The Experts below are selected from a list of 138267 Experts worldwide ranked by ideXlab platform
Ji-shuang Zhao - One of the best experts on this subject based on the ideXlab platform.
-
Clinicopathological characteristics and prognosis of mucinous Breast Carcinoma
Journal of cancer research and clinical oncology, 2013Co-Authors: Ming Zhang, Xiao-dan Teng, Xin-xin Guo, Ji-shuang ZhaoAbstract:Purpose The clinical features and prognosis of mucinous Breast Carcinoma (MBC) are unclear because of its rarity. The aim was to describe the clinicopathological features and prognosis of patients with MBC in comparison with nonmucinous Breast Carcinoma (NMBC). Furthermore, we described the biological behavior of pure mucinous Breast Carcinoma (PMBC) by comparing clinicopathological features and prognosis with mixed mucinous Breast Carcinoma (MMBC).
Uma Krishnamurti - One of the best experts on this subject based on the ideXlab platform.
-
GATA3 immunohistochemistry expression in histologic subtypes of primary Breast Carcinoma and metastatic Breast Carcinoma cytology.
The American journal of surgical pathology, 2015Co-Authors: Georgios Deftereos, Angela M. Sanguino Ramirez, Jan F. Silverman, Uma KrishnamurtiAbstract:GATA3 plays a role in cell proliferation and differentiation in many tissues, including Breast, and it has been suggested that GATA3 expression correlates with ER expression. However, little is known on GATA3 expression in various subtypes of Breast Carcinoma, its utilization in cytology, and on how GATA3 performs in comparison with GCDFP-15 and mammaglobin. Eighty-four histology cases of Breast Carcinoma of various subtypes, including 28 triple-negative Breast Carcinomas, along with 20 cytology cases of metastatic Breast Carcinoma and 12 cytology cases of ER-positive metastatic gynecologic malignancies, were stained for GATA3, GCDFP-15, and mammaglobin. In non-triple-negative Breast Carcinomas (n=56), GATA3 showed 100% sensitivity, higher than GCDFP-15 (42.8%; P
Giles Davies - One of the best experts on this subject based on the ideXlab platform.
-
Primary ectopic Breast Carcinoma of the axilla in a male patient
Journal of Surgical Case Reports, 2017Co-Authors: Daniel Ching, Giles DaviesAbstract:Primary ectopic Breast Carcinoma in male is very rare. We report a case on a 52-year-old gentleman who presented initially with bilateral lesions in his axilla and after delayed diagnosis the right lesion was confirmed as an ectopic Breast Carcinoma. We reviewed the literature and discussed the significance of the case.
Ming Zhang - One of the best experts on this subject based on the ideXlab platform.
-
Clinicopathological characteristics and prognosis of mucinous Breast Carcinoma
Journal of cancer research and clinical oncology, 2013Co-Authors: Ming Zhang, Xiao-dan Teng, Xin-xin Guo, Ji-shuang ZhaoAbstract:Purpose The clinical features and prognosis of mucinous Breast Carcinoma (MBC) are unclear because of its rarity. The aim was to describe the clinicopathological features and prognosis of patients with MBC in comparison with nonmucinous Breast Carcinoma (NMBC). Furthermore, we described the biological behavior of pure mucinous Breast Carcinoma (PMBC) by comparing clinicopathological features and prognosis with mixed mucinous Breast Carcinoma (MMBC).
Georgios Deftereos - One of the best experts on this subject based on the ideXlab platform.
-
GATA3 immunohistochemistry expression in histologic subtypes of primary Breast Carcinoma and metastatic Breast Carcinoma cytology.
The American journal of surgical pathology, 2015Co-Authors: Georgios Deftereos, Angela M. Sanguino Ramirez, Jan F. Silverman, Uma KrishnamurtiAbstract:GATA3 plays a role in cell proliferation and differentiation in many tissues, including Breast, and it has been suggested that GATA3 expression correlates with ER expression. However, little is known on GATA3 expression in various subtypes of Breast Carcinoma, its utilization in cytology, and on how GATA3 performs in comparison with GCDFP-15 and mammaglobin. Eighty-four histology cases of Breast Carcinoma of various subtypes, including 28 triple-negative Breast Carcinomas, along with 20 cytology cases of metastatic Breast Carcinoma and 12 cytology cases of ER-positive metastatic gynecologic malignancies, were stained for GATA3, GCDFP-15, and mammaglobin. In non-triple-negative Breast Carcinomas (n=56), GATA3 showed 100% sensitivity, higher than GCDFP-15 (42.8%; P